Alpheus Medical (Series B)
Funding Details
Awarder
RSS - feeds.feedburner.com
Date Award
May 19, 2025
Vertical
Oncology
Funding URL
View Funding Page
Funding Amount
$52,000,000
Company Info
Traction
The funds will support a Phase 2B randomized controlled trial (RCT) evaluating the efficacy of SDT in patients with newly diagnosed glioblastoma (GBM).
Market
Cancer treatment
Location
Chanhassen, Minnesota, USA
Coinvestors
HealthQuest Capital, Samsara BioCapital, OrbiMed, Action Potential Venture Capital, BrightEdge, Brain Tumor Investment Fund, Sontag Innovation Fund
Company Description

Alpheus Medical is a private, clinical-stage oncology company pioneering sonodynamic therapy (SDT) for the treatment of solid body cancers. The company is developing a non-invasive treatment utilizing a proprietary platform that combines Low-Intensity Diffuse Ultrasound (LIDU™) with oral 5-aminolevulinic acid (5-ALA) to selectively target and destroy cancer cells while sparing healthy tissue.

Links
Website
Back to HomeBack to Oncology DealsView Funding Announcement